This paper is in the following e-collection/theme issue:

Pharmacovigilance (129) JMIR Theme Issue: COVID-19 Special Issue (2394) Infectious Diseases (non-STD/STI) (1490) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (147) Pharmacology and Pharmaceutics (52) COVID-19 Vaccination (128) Vaccination and Immunization in the Digital Age (347)

Published on in Vol 9 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/45263, first published .
Safety Signal Generation for Sudden Sensorineural Hearing Loss Following Messenger RNA COVID-19 Vaccination: Postmarketing Surveillance Using the French Pharmacovigilance Spontaneous Reporting Database

Safety Signal Generation for Sudden Sensorineural Hearing Loss Following Messenger RNA COVID-19 Vaccination: Postmarketing Surveillance Using the French Pharmacovigilance Spontaneous Reporting Database

Safety Signal Generation for Sudden Sensorineural Hearing Loss Following Messenger RNA COVID-19 Vaccination: Postmarketing Surveillance Using the French Pharmacovigilance Spontaneous Reporting Database

Authors of this article:

Hung Thai-Van1, 2, 3 Author Orcid Image ;   Marie-Blanche Valnet-Rabier4 Author Orcid Image ;   Maëva Anciaux2 Author Orcid Image ;   Aude Lambert5 Author Orcid Image ;   Anaïs Maurier6 Author Orcid Image ;   Judith Cottin7 Author Orcid Image ;   Tessa Pietri8 Author Orcid Image ;   Alexandre Destère9 Author Orcid Image ;   Marlène Damin-Pernik10 Author Orcid Image ;   Fanny Perrouin11 Author Orcid Image ;   Haleh Bagheri12 Author Orcid Image
Article Authors Cited by (4) Tweetations (894) Metrics

Hung Thai-Van   1, 2, 3 * , MD, PhD ;   Marie-Blanche Valnet-Rabier   4 * , PharmD, PhD ;   Maëva Anciaux   2 , MD ;   Aude Lambert   5 , PharmD ;   Anaïs Maurier   6 , PharmD ;   Judith Cottin   7 , PharmD ;   Tessa Pietri   8 , PharmD ;   Alexandre Destère   9 , PharmD ;   Marlène Damin-Pernik   10 , PharmD ;   Fanny Perrouin   11 , PharmD ;   Haleh Bagheri   12 , PharmD, PhD

1 Service d’Audiologie & d’Explorations Otoneurologiques, Hospices civils de Lyon, Lyon, France

2 Département d'audiologie et d'Explorations otoneurologiques, Hôpital Universitaire de lyon 1, Villeurbanne, France

3 Institut de l'Audition, Institut Pasteur, Paris, France

4 Regional Pharmacovigilance Center of Franche-Comté, Centre Hospitalier Universitaire de Besançon, Besançon, France

5 Regional Pharmacovigilance Center of Strasbourg, Hôpitaux Universitaires de Strasbourg, Strasbourg, France, Strasbourg, France

6 Service de Pharmacosurveillance, Centre Régional de Pharmacovigilance du Centre Val de Loire, Centre Hospitalier Universitaire, Tours. France, Tours, France

7 Regional Pharmacovigilance Center of Lyon, Service Hospitalo-Universitaire de Pharmaco-Toxicologie, Hospices Civils de Lyon, Lyon, France, Lyon, France

8 Regional Pharmacovigilance Center of Marseille, Service de Pharmacologie Clinique et Pharmacovigilance, Aix Marseille Université, Assistance Publique Hôpitaux de Marseille, Marseille, France, Marseille, France

9 Department of Pharmacology and Pharmacovigilance Center, Côte d'Azur University Medical Center, Nice, France, Nice, France

10 Regional Pharmacovigilance Center of Saint-Etienne, Centre Hospitalier Universitaire de Saint-Étienne, Saint-Étienne, France, Saint Etienne, France

11 Regional Pharmacovigilance Center of Nantes, Service de Pharmacologie Clinique, Nantes, France, Nantes, France

12 Department of Medical and Clinical Pharmacology, Regional Pharmacovigilance Center of Toulouse, CIC1436, Toulouse University Hospital, Toulouse, France

*these authors contributed equally

Corresponding Author:

  • Haleh Bagheri, PharmD, PhD
  • Department of Medical and Clinical Pharmacology
  • Regional Pharmacovigilance Center of Toulouse, CIC1436
  • Toulouse University Hospital
  • 37 Allées Jules Guesde
  • Toulouse, 31000
  • France
  • Phone: 33 561145902
  • Fax: 33 561255116
  • Email: haleh.bagheri@univ-tlse3.fr